!-- HERO SECTION -->

Urethral Cancer Treatment
Comprehensive Surgical Care by Dr. Lovedeep Singh Chauhan

Dr. Lovedeep Singh Chauhan
  • Urethral cancer is one of the rarest urological malignancies, yet when it occurs, it demands precise diagnosis, expert surgical planning, and coordinated multidisciplinary management. Because of its uncommon nature, many patients experience delays in diagnosis or are initially treated for benign urinary conditions. Early recognition and specialist intervention significantly improve outcomes.

  • At Max Super Speciality Hospital, Mohali, Dr. Lovedeep Singh Chauhan provides evidence-based, comprehensive treatment for urethral cancer, combining oncologic safety with functional preservation whenever feasible. With advanced surgical training and experience in managing rare malignancies, he offers individualized care tailored to each patient’s stage, health condition, and personal priorities.

  • Understanding Urethral Cancer

  • The urethra is a thin muscular tube responsible for transporting urine from the bladder to the outside of the body. In men, it also carries semen. Because male and female urethras differ anatomically, disease behavior and treatment strategies may vary between genders.

    • The anterior urethra (closer to the external opening)
    • The posterior urethra (closer to the bladder)
  • Urethral cancer develops when abnormal cells grow uncontrollably within the lining of the urethra. Although rare compared to bladder or prostate cancer, it can be locally aggressive if not detected early. Tumors in the posterior urethra often behave more aggressively due to proximity to surrounding organs.

  • Multiple Endocrine Neoplasia Illustration

    Types of Urethral Cancer

    Urothelial (Transitional Cell) Carcinoma

    This type arises from the urothelial lining, similar to bladder cancer. It may coexist with bladder tumors and requires careful evaluation of the entire urinary tract.

    Squamous Cell Carcinoma

    Often associated with chronic inflammation, urethral strictures, or infections. This subtype is commonly seen in the distal (anterior) urethra.

    Adenocarcinoma

    A rare subtype that develops from glandular cells. It requires specialized management based on its unique biological behavior.

    The histological subtype plays a crucial role in determining treatment strategy, prognosis, and the need for chemotherapy or radiation therapy.

    Causes and Risk Factors

    While no single cause has been identified, several factors increase susceptibility:

    • Chronic urethral inflammation
    • Long-standing urethral strictures
    • Recurrent urinary tract infections
    • HPV infection
    • History of bladder cancer
    • Long-term catheterization
    • Smoking

    Chronic irritation of the urethral lining plays a significant role. Persistent urinary symptoms should always be evaluated rather than assumed to be benign.

    Symptoms of Urethral Cancer

    Symptoms often resemble common urinary disorders, which may delay diagnosis. Warning signs include:

    • Blood in urine (hematuria)
    • Painful urination
    • Weak urine stream
    • Urinary retention
    • Palpable mass in genital or perineal region
    • Abnormal urethral discharge
    • Enlarged groin lymph nodes

    In advanced cases, pelvic pain or obstructive urinary symptoms may occur. Any persistent or unexplained symptom should prompt specialist consultation.

    Diagnostic Evaluation and Staging

    Accurate diagnosis and staging form the foundation of effective treatment. Because urethral cancer is rare, evaluation must be systematic and thorough.

    Clinical Examination

    A detailed examination assesses local tumor extent and lymph node involvement.

    Cystoscopy with Biopsy

    A camera is inserted through the urethra to visualize the tumor and obtain tissue for histopathological confirmation.

    MRI Pelvis

    MRI helps determine depth of invasion and involvement of surrounding organs.

    CT Scan

    CT scan of the chest, abdomen, and pelvis is used to detect distant spread.

    PET-CT

    Reserved for selected advanced cases to evaluate metastatic disease.

    Lymph Node Assessment

    Suspicious inguinal lymph nodes may require biopsy for accurate staging.

    Staging determines whether the disease is localized, locally advanced, or metastatic. Treatment planning is based on stage to ensure optimal outcomes.

    Treatment of Urethral Cancer

    Management depends on tumor location, stage, histology, lymph node involvement, and overall patient health. Treatment is individualized to achieve optimal cancer control while preserving function whenever possible.

    Surgical Treatment

    Surgery is the cornerstone for most localized and locally advanced urethral cancers. Procedures may include:

    • Local excision for small distal tumors
    • Partial urethrectomy
    • Total urethrectomy
    • Cystoprostatectomy (selected male cases)
    • Anterior exenteration (selected female cases)
    • Inguinal lymph node dissection

    The goal is complete tumor removal with clear margins while preserving urinary and sexual function whenever oncologically safe.

    Chemotherapy

    Chemotherapy may be used before surgery (neoadjuvant), after surgery (adjuvant), or as primary treatment in metastatic disease.

    Multimodality therapy often improves survival outcomes in advanced urethral cancer.

    Radiation Therapy

    Radiation therapy may be considered as definitive treatment in selected early-stage cases, as adjuvant therapy, or for palliation in metastatic disease.

    The choice between surgery and radiation depends on tumor location, stage, and patient preference.

    Functional Considerations and Quality of Life

    Treatment planning for urethral cancer focuses not only on disease control but also on preserving overall well-being and quality of life.

    • Urinary continence preservation
    • Maintenance of sexual function
    • Protection of body image
    • Support for psychological well-being
    Reconstructive options are considered when extensive surgery is required, ensuring both effective cancer treatment and long-term quality of life.

    Why Expert Management Matters

    Due to its rarity, urethral cancer requires specialized care. Timely diagnosis and expert treatment significantly improve outcomes.

    • Accurate pathological evaluation
    • Multidisciplinary tumor board discussions
    • Individualized surgical planning
    • Evidence-based chemotherapy protocols
    • Structured follow-up surveillance
    Inadequate treatment or delayed diagnosis can significantly impact survival, making expert oncologic care essential.

    Urethral Cancer Treatment by Dr. Lovedeep Singh Chauhan

    Dr. Lovedeep Singh Chauhan is a Consultant Surgical Oncologist in punjab at Max Super Speciality Hospital, Mohali with specialized training in complex oncologic surgeries. His background at Tata Memorial Hospital—one of India’s leading cancer institutes—ensures adherence to internationally accepted treatment protocols.

    Areas of Strength in Urological & Pelvic Malignancies:

    • Management of rare cancers
    • Advanced pelvic oncologic surgery
    • Lymph node dissection techniques
    • Multidisciplinary cancer coordination
    • Patient-centered decision-making

    Each case is evaluated in detail, and treatment plans are individualized rather than standardized to ensure the best possible outcomes.

    Symptoms of Bladder Cancer

    Multidisciplinary Approach to Care

    Cancer treatment is rarely one-dimensional. Urethral cancer management may involve:

    • Surgical oncology
    • Medical oncology
    • Radiation oncology
    • Radiology
    • Pathology
    • Rehabilitation and counseling services

    At Max Super Speciality Hospital, Mohali, cases are discussed in tumor board meetings to ensure comprehensive planning.

    Recovery and Follow-Up

    Post-treatment monitoring is crucial to detect recurrence early.

    • Periodic clinical examination
    • Imaging studies
    • Surveillance cystoscopy when indicated
    • Monitoring of urinary function

    Structured follow-up ensures long-term safety and quality of life.

    When to Seek Consultation

    You should consult a specialist if you experience:

    • Persistent blood in urine
    • Unexplained urinary obstruction
    • Recurrent urethral infections
    • Newly detected urethral mass
    • Enlarged groin lymph nodes

    Early evaluation significantly improves the chances of successful treatment.

    Have a Question? Get In Touch

    whatsapp-mobi
    h-call
    Call Dr. Lovedeep Singh Chauhan
  • Book An Appointment